Philip E Dawson Selected Research

Philip E Dawson Research Topics

3	Neoplasms (Cancer) 12/2023 - 12/2002
2	Infections 12/2010 - 02/2010
1	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2023
1	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 01/2021
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2021
1	Constipation 01/2021
1	Abdominal Pain (Pain, Abdominal) 01/2021
1	Atherosclerosis 10/2020
1	Human Influenza (Influenza) 01/2019
1	Parkinson Disease (Parkinson's Disease) 01/2018
1	Type 2 Diabetes Mellitus (MODY) 12/2015
1	Inflammation (Inflammations) 12/2015
1	Pathologic Constriction (Stenosis) 12/2010
1	Alkalosis 08/2010
1	Neuronal Ceroid-Lipofuscinoses (Neuronal Ceroid Lipofuscinosis) 04/2010
1	Lysosomal Storage Diseases (Lysosomal Storage Disease) 04/2010

3	Proteins (Proteins, Gene)FDA Link 01/2019 - 12/2002
2	Peptides (Polypeptides)IBA 01/2021 - 01/2019
2	palmitoyl-protein thioesteraseIBA 04/2010 - 12/2002
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 12/2023
1	EphA4 ReceptorIBA 12/2023
1	linaclotideIBA 01/2021
1	CC ChemokinesIBA 10/2020
1	LigandsIBA 10/2020
1	ChemokinesIBA 10/2020
1	DNA Ligases (Ligases, DNA)IBA 01/2019
1	SynucleinsIBA 01/2018
1	Inosine Diphosphate (IDP)IBA 01/2018
1	Glucagon-Like Peptide 1 (GLP 1)IBA 12/2015
1	Exenatide (Byetta)FDA Link 12/2015
1	GTP-Binding Proteins (G-Protein)IBA 12/2015
1	VaccinesIBA 12/2010
1	Broadly Neutralizing AntibodiesIBA 12/2010
1	Dopamine (Intropin)FDA LinkGeneric 08/2010
1	HydrolasesIBA 04/2010
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 03/2010
1	HydrazonesIBA 03/2010
1	Indicators and Reagents (Reagents)IBA 02/2010

1	Therapeutics 04/2010
1	Ligation 03/2010